AbCellera Biologics Inc. (ABCL) quarterly cash flow statement — complete operating, investing & financing history
AbCellera Biologics Inc. (ABCL) cash flow statement — 8-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -33.86M | -33.52M | -34.74M | -52.59M | -32.4M | -11.55M | -8M | -29M | -29.46M | -41.71M | -19.61M | -106K | 19.82M | -44.06M | 30.91M | -126.79M | 271.51M | 100.22M | -16.71M | -5.93M |
| Operating CF Margin % | -836.12% | -403.16% | -77.46% | -587.31% | -189.67% | -272.82% | -158.42% | -445.63% | -402.28% | -419.01% | -213.65% | -1.61% | 197.07% | -361.41% | 143.48% | -125.06% | 591.31% | 31.66% | -11.99% | -107.7% |
| Operating CF Growth % | -4.5% | -190.14% | -334.29% | -81.37% | -10% | 72.3% | 59.21% | -27256.05% | -248.65% | 5.34% | -163.44% | 99.92% | -92.7% | -143.97% | 284.97% | -2037.32% | 67.77% | -8.51% | -1110.9% | -56.06% |
| Net Income | -98.59M | -43.16M | -8.95M | -57.12M | -34.73M | -45.62M | -34.21M | -51.11M | -36.93M | -40.61M | -47.15M | -28.61M | -30.53M | -40.11M | -29.89M | 26.62M | -6.79M | 168.57M | 59.95M | -21.38M |
| Depreciation & Amortization | 5.17M | 8.65M | 8.99M | 7.24M | 7.06M | 6.61M | -18.1M | 38.3M | 38.04M | 6.77M | 9.11M | 7.41M | 7.26M | 7.12M | 15.36M | 6.73M | 6.04M | 4.97M | 4.86M | 4.21M |
| Stock-Based Compensation | 12.29M | 12.01M | 12.9M | 13.89M | 14.21M | 14.79M | 15.23M | 0 | 0 | 17.41M | 16.45M | 15.86M | 0 | 15.47M | 13.32M | 11.75M | 0 | 12.29M | 9.04M | 7.71M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.25M | -4.02M |
| Other Non-Cash Items | 50.49M | 2.38M | -1.7M | 1.53M | -2.14M | 2.21M | 45M | -10.37M | -22.78M | 1.71M | -1.39M | -1.93M | 15.5M | -3.63M | 3.13M | -82.74M | 11.61M | -592K | 2.68M | 1.31M |
| Working Capital Changes | -3.22M | -13.4M | -45.99M | -18.14M | -16.8M | 10.46M | -15.91M | -5.82M | -7.79M | -26.98M | 1.41M | 7.16M | 27.59M | -22.91M | 28.99M | -89.15M | 260.64M | -85.03M | -94.49M | 6.25M |
| Change in Receivables | -13.1M | 13.1M | -39.54M | 4.16M | -18.98M | -1.13M | -20.86M | -19.86M | -15.61M | -18.58M | -10.44M | -11.21M | -32.24M | 17.18M | 66.17M | -59.33M | 275.88M | -176.66M | -137.52M | 15.57M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -7.21M | -9.41M | 5.79M | 5.07M | -3.95M | -3.41M | 0 | 4.13M | 4.75M | -4.88M | -13.25M | 975K | 2.94M | -5.78M | 2.22M | 0 | -2.63M | 751K | 1.71M | 3.33M |
| Cash from Investing | 11.34M | -25.08M | 75.14M | 36.49M | -31.81M | 7.93M | 35.7M | 3.94M | 51.52M | 29.91M | -24.32M | -12.79M | -35.04M | -149.61M | -17.06M | -281.99M | -26.98M | -26.37M | -1.15M | -269.63M |
| Capital Expenditures | -2.13M | -3.83M | -9.84M | -8.93M | -13.37M | -10.64M | -15.63M | -18.58M | -19.8M | -24.14M | -14.43M | -20.33M | -27.35M | -14.98M | -12.33M | -12.51M | -31.14M | -14.49M | -9.43M | -8.57M |
| CapEx % of Revenue | 52.64% | 46.07% | 21.95% | 99.7% | 78.23% | 251.15% | 309.5% | 285.61% | 270.34% | 242.52% | 157.22% | 308.09% | 271.98% | 122.9% | 57.23% | 12.34% | 67.81% | 4.58% | 6.77% | 155.66% |
| Acquisitions | 0 | 0 | -2.55M | -2.45M | -2.55M | -1.88M | -1.67M | 0 | 0 | -5.91M | -3.48M | -3.54M | 0 | -4.47M | -5.91M | 0 | 0 | 0 | -3.22M | -18.05M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 299.05M | 1.36M | 93.64M | 918K | 5.43M | 2.9M | 6.56M | 9.43M | 12.44M | 7.17M | 10.29M | 7.33M | 5.03M | 2.69M | 2.33M | -269.48M | 5.47M | 2.6M | 22.81M | 5.29M |
| Cash from Financing | 13.59M | 7.19M | 4.12M | 7.37M | -3.38M | 5.97M | 4.14M | 3.15M | 2.61M | 2.83M | 3.77M | 6.63M | 418.86K | -458K | 349K | -19K | 1.18M | -3.13M | 1.83M | 898K |
| Debt Issued (Net) | 0 | 7.19M | 10.52M | 7.55M | 5.5M | 6.15M | 5.9M | -4.47M | 2.34M | 2.12M | 3.95M | 7.03M | 1.59M | 490K | 2.75M | 231K | -706 | -72K | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | -1.58M | 230.42K | 451.43K | 892K | 0 | 0 | -490K | 0 | 0 | 0 | 225.24K | 1.94M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -1.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 13.59M | 0 | -6.41M | -182K | -8.88M | -178K | -177K | 7.38M | -180.4K | -185K | -185K | -374.02K | -679.39K | -948K | -2.41M | -250K | 956.36K | -5M | 1.83M | 898K |
| Net Change in Cash | -7.87M | -52.95M | 44.8M | -9.28M | -66.83M | 2.94M | 29.68M | -21.67M | 24.74M | -9.75M | -39.1M | -7.33M | -13.27M | -194.34M | 14.56M | -417.35M | 244.9M | 69.58M | -16.55M | -274.88M |
| Free Cash Flow | -35.99M | -37.35M | -44.59M | -61.52M | -45.77M | -22.19M | -23.63M | -47.58M | -49.26M | -65.85M | -34.04M | -20.44M | -7.53M | -59.05M | 18.58M | -139.3M | 240.37M | 85.72M | -26.14M | -14.51M |
| FCF Margin % | -888.77% | -449.24% | -99.4% | -687.01% | -267.91% | -523.97% | -467.92% | -731.24% | -672.62% | -661.52% | -370.87% | -309.7% | -74.91% | -484.31% | 86.25% | -137.4% | 523.5% | 27.08% | -18.76% | -263.36% |
| FCF Growth % | 21.36% | -68.34% | -88.68% | -29.3% | 7.08% | 66.3% | 30.59% | -132.82% | -553.91% | -11.52% | -283.2% | 85.33% | -103.13% | -168.88% | 171.08% | -860.29% | 93.22% | -19.05% | -116035.05% | -88.73% |
| FCF per Share | -0.12 | -0.12 | -0.15 | -0.21 | -0.15 | -0.07 | -0.08 | -0.16 | -0.17 | -0.22 | -0.12 | -0.07 | -0.03 | -0.21 | 0.06 | -0.44 | 0.84 | 0.28 | -0.08 | -0.05 |
| FCF Conversion (FCF/Net Income) | 0.61x | 0.78x | 3.88x | 0.92x | 0.93x | 0.25x | 0.23x | 0.57x | 0.80x | 1.03x | 0.42x | 0.00x | -0.65x | 1.10x | -1.03x | -4.76x | -40.02x | 0.59x | -0.28x | 0.28x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |